Selective GABA transporter inhibitors tiagabine and EF1502 exhibit mechanistic differences in their ability to modulate the ataxia and anticonvulsant action of the extrasynaptic GABA(A) receptor agonist gaboxadol
The role of IGF-II should be viewed in the light of Efstradiadis series of knock-out experiments in mice (21) where the Igf2 ko mice had the same degree of fetal growth retardation as the igf1 ko which demonstrates that IGF-II is a paracrine/autocrine and not an endocrine hormone
Conclusions The findings suggest significant reductions in HbA1c and FBG levels by about 0.13% to 0.51% and 8 mg/dL, respectively, after turmeric supplementation, especially with bioavailability-enhanced and curcuminoid extract preparations
With the added concern about B12-tirzepatide interactions producing impurities over time, using fresh product within its dating window becomes even more important
The emergence of GLP-1 agonists and SGLT-2 inhibitors, with their renal protective effects, may offer new avenues for improving outcomes in this patient population
